Development of liposome for targeting therapy against brain tumor.

Shobu Shibata, Nobutoshi Ryu, Akira Ochi, Takafumi Jinnouchi, Toshinori Sato, Junzo Sunamoto, Masami Hirai, Kenji Matsuyama

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Liposomes were investigated as a carrier for the delivery of therapeutic agents to target brain tumors. We have developed the coating of liposomes with pullulan and 1-aminolactose pullulan, and compared with conventional neutral liposome. When pullulan-coated liposome labeled with14 C was intracarotidly administrated into the 9L cells immlanted brain tumor rats, brain tumor uptake of radioactivity increased 4.5 times and spleen uptake decrease compared with the neutral liposome. The cytotoxity of cisplatin against 9L-glioma cells was not inhibited by encapsulation of pullulan-coated liposmes. The quantity of platinum of 1-aminolactose pullulan-coated liposome-encapsulated cisplatin into the brain tumor was about 4 times as great as that of pullulan-coated liposome-encapsulated cisplatin. Considering that polysaccharide-coated liposomes become more stable, both physio chemically and biochemically, than conventional liposomes, 1-aminolactose pullulan-coated liposomes may be useful in targeting brain tumors.

Original languageEnglish
Pages (from-to)109-114
Number of pages6
JournalDrug Delivery System
Issue number2
Publication statusPublished - 1992
Externally publishedYes


  • 1-aminolactose
  • 9L rat brain tumor
  • cisplatin
  • liposome
  • pullulan

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'Development of liposome for targeting therapy against brain tumor.'. Together they form a unique fingerprint.

Cite this